Eisai/Biogen’s Leqembi Will Launch Below Aduhelm At $26,500 Per Year

Available For Commercially Insured Patients By Mid-Month

 
• By Mandy Jackson
Brown price tag on wooden background
Eisai determined Leqembi's "societal value" is as high as $37,600 but set its list price at $26,500 • Source: Shutterstock

More from New Products

More from Scrip